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The aim of this thesis was to explore the possible associations between fatty acids (FA) profile and 
gut microbiota (gMb) with several conditions throughout the lifespan, from infancy to old age. In 
particular, we focused our attention on elderly subjects with Chronic Kidney Disease (CKD) and 
children with	Acute Otitis Media (AOM).  
The terms “Chronic Kidney Disease” refers to several disorders with a progressive kidney function 
decline. International guidelines approved the definition of CKD as a condition with the presence of 
markers of kidney damage or with the estimated glomerular filtration rate (eGFR) less than 60 
ml/min/1.73 m2 or both, for at least three months. End-stage renal disease is associated with a high 
cardiovascular disease (CVD) risk, the major cause of death in these patients. Chronic 
inflammation, oxidative stress, protein-energy wasting, disordered mineral metabolism, and 
deficiency of endogenous calcification inhibitors, known as non-traditional risks factor, take part in 
cardiovascular pathology in CKD. Inflammatory processes influence the physiological response to 
renal infection and injury but also participate in the development of potentially irreversible kidney 
damage with the production of various inflammatory molecular species, among whom eicosanoids 
and cytokines, from parental omega-6 long-chain polyunsaturated fatty acids (LCPUFA). Several 
studies focused their attention on the potential role of omega-3 (n-3) LCPUFA supplementation in 
subjects with CKD. Despite this, their effect on kidney damage is still not clear. However, it is 
widely agreed that a modified FA profile in CKD can determine a progression of the disease, 
inducing the inflammatory state. Moreover, high/normal n-3 LCPUFA levels decrease the risk of a 
decline of the disease. Omega-3 and omega-6 (n-6) LCPUFA concentrations and their ratios are 
tightly associated with renal health, because of their important roles in different pathways. Another 
aspect not very considered in the field of CKD is the role of circulating FA levels and their 
metabolites on the modulation of inflammation. The first aim of this study is to analyze the FA 
profile in elderly subjects with CKD. Blood samples have been collected from 57 subjects enrolled 
in the study, and FA analysis has been performed. During the last years, several studies underlined 
the strong relationship between intestinal inflammation and adverse outcomes in CKD. The health 
of gastrointestinal tract is fundamental to ensure the well being of the host contributing to its 
nutrition, metabolism, physiology, and immune function. The bacterial communities colonizing 
humans have been seen in terms of mutualistic symbiosis with their hosts, a mutually beneficial 
coexistence, playing an important role in health and disease. Abnormal colonization or changes in 
the gut microbial composition determine dysbiosis, a state associated with different illnesses, such 
as obesity, type 2 diabetes, inflammatory bowel disease, cardiovascular disease, and also chronic 
kidney disease. The relationship between gut and kidney is a bi-directional relation with a mutual 
influence. Chronic kidney disease influences gMB characteristics, especially through high levels of 
urea that easily spread in the intestinal fluid where bacterial urease enzymes degrade it, then it is 
hydrolyzed in ammonium hydroxide that increases fecal pH with a consequent alteration of 
intestinal cellular junctions. Besides, high levels of urea change intestinal microbiota composition 
damaging permeability of intestinal barrier and promoting proteolysis with production and 
absorption of uremic toxins, such as indoxyl sulfate (IS) and p-cresol sulfate (p-CS). These toxins 
induce an inflammatory process associated with CKD. Under physiologic conditions, the kidney 
through the urine eliminates these compounds, but CKD patients have a compromised renal 
clearance. Therefore, these solutes tend to accumulate in the organs. IS and p-CS are tightly bound 
to human serum albumin (HSA), the most abundant plasma protein in the bloodstream. HSA is 
recognized as the main means of transport for endogenous and exogenous compounds, including 
fatty acids that seem to be the main endogenous ligand of HSA, multiple binding sites are used for 
monounsaturated fatty acids (MUFA) and PUFA. Thus, free fatty acids and uremic toxins compete 
for the same binding sites on HSA. It is important to assess fatty acid (FA) levels in patients with 
CKD because of the potential role to contrast the accumulation of uremic toxins derived from the 
intestinal bacterial community. As a consequence of this bi-directional relation between gut and 
kidney and the possible involvement of some compounds as metabolites of FA in the inflammatory 
response, we investigate the correlation between circulating FA levels and the gMB composition in 
the same subjects with CKD, as the second aim of this thesis. 64 old CKD non-dialysis patients 
(eGFR 15-45 ml/min/1.73 m2) and 15 elderly subjects (>65 years) with normal renal function 
(eGFR >60 ml/min/1.73 m2, CKD-EPI) are enrolled. Bacterial composition was studied in a 
previous observational study by denaturating gel gradient electrophoresis (DGGE), high-throughput 
sequencing (16S ribosomal RNA), and quantitative real-time PCR (qPCR). This study described an 
increased abundance of some bacteria associated with pathological conditions. In agreement with 
the literature, the author found a reduced abundance of saccharolytic and butyrate-producing 
bacteria (Prevotella, Faecalibacterium prausnitzii, Roseburia) in CKD patients respect to the 
control group. Butyrate plays a crucial role in the maintenance of the gut barrier function. Taking 
that into account, we decided to investigate the correlation between gMB composition and FA 
profile in these subjects. The main result of the study was the significant positive correlation 
between Faecalibacterium prausnitzii and total n-3 levels, both associated with the anti-
inflammatory action. The present doctoral thesis underlines the need to perform further 
investigations in order to support evidence presented. Future studies may be useful to improve 
understanding of the effect of circulating fatty acids levels and their metabolites on gut microbial 
composition, inflammation process, and pathological conditions such as kidney disease. Our results 
showed that CKD patients with previous cardiovascular events had lower total and specific n-3 
levels comparing with patients without them. Moreover, higher docosahexaenoic acid (DHA) levels 
and having had previous cardiovascular events seemed to have protective effects against further 
cardiovascular events. Moreover, we observed a significant reduction of the 
genera Roseburia and Faecalibacterium in CKD patients compared to C group and a significant 
lower abundance of F. prausnitzii and Roseburia spp. in CKD patients. Thus, our results seem in 
accordance with anti-inflammatory actions of total n-3, DHA, and saccharolytic and butyrate-
producing bacteria. Many gMB changes seem to be related both to CKD and CVD. If the different 
gMB composition might play a causal role in cardiovascular events by an unbalanced production of 
some toxic substances, or if the gMB changes are merely a consequence of different dietary and 
lifestyle behaviours of these patients, it cannot be explained by the present study and all the yet 
available data. Further studies, possibly utilizing new high-throughput tools, will be required to 
understand the potential correlations between the gMB composition and other inflammation and 
oxidative stress markers in these patients. Other two studies have been performed during the 
doctoral course, to reach a better comprehension of fatty acids, gut microbial community and 
inflammatory states. A prospective pilot clinical study has been performed to to explore possible 
changes of gMB composition in children with AOM treated with amoxicillin with or without 
clavulanic acid. AOM is one of the most common bacterial infections in children and is normally 
treated with antibiotic therapies that lead to increasing antimicrobial resistance rates among 
otopathogens and may impair the correct development of the microbiota in early life. No significant 
differences were shown in the gMB composition of the overall cohort at different time intervals of 
the samples collection and in subjects treated with amoxicillin with or without clavulanic acid at 
different time intervals (T0, T1 and T2). A literature revision on lipids in infant formulae has been 
performed to better understanding quality and quality of dietary lipids because of their significant 
impact on health outcomes, especially when fat storing and/or absorption are limited (e.g., preterm 
birth and short bowel disease) or when fat byproducts may help to prevent some pathologies. The 
lipid composition of infant formulae varies according to the different fat sources used, and the 
potential biological effects are related to the variety of saturated and unsaturated FAs. Instead, 
ruminant-derived trans FAs and metabolites of n-3 LCPUFA with their anti-inflammatory 
properties can modulate immune function. Furthermore, dietary fats may influence the nutrient 
profile of formulae, improving the acceptance of these products and the compliance with dietary 
schedules. During the doctoral course, I spent a period abroad at Dell Pediatric Research Institute 
(DPRI), The University of Texas at Austin. In particular, I attended the laboratory of Doctor 
Brenna. I focused my research activity on a specific regulatory insertion-deletion polymorphism in 
the FADS gene cluster for better understanding its influence on PUFA and lipid profile. 
